Literature DB >> 15198736

Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells.

Kennosuke Karube1, Koichi Ohshima, Takeshi Tsuchiya, Takahiro Yamaguchi, Riko Kawano, Junji Suzumiya, Atae Utsunomiya, Mine Harada, Masahiro Kikuchi.   

Abstract

Adult T-cell leukaemia/lymphoma (ATLL) is an aggressive neoplastic disease that usually exhibits a CD4(+)CD25(+) phenotype. Regulatory T cells (Treg), which suppress T-cell effector function, are characterized by the co-expression of CD4 and CD25. We analysed the expression of forkhead/winged helix transcription factor (FoxP3), a specific marker that is important for the function of Treg, on ATLL cells from 17 patients (peripheral blood, n = 8; lymph node, n = 9). Real-time polymerase chain reaction and immunostaining detected FoxP3 expression in 10 ATLL cases, but was relatively down-regulated compared with Treg from normal subjects. These results indicate the association of ATLL and Treg.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198736     DOI: 10.1111/j.1365-2141.2004.04999.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  66 in total

Review 1.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

2.  Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.

Authors:  Alaa Refaat; Yue Zhou; Shunsuke Suzuki; Ichiro Takasaki; Keiichi Koizumi; Shoji Yamaoka; Yoshiaki Tabuchi; Ikuo Saiki; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

Review 3.  Regulatory T-cell compartmentalization and trafficking.

Authors:  Shuang Wei; Ilona Kryczek; Weiping Zou
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

4.  Adult T-cell leukemia/lymphoma.

Authors:  Robbie L Graham; Micah Burch; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-07

5.  Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1.

Authors:  Zhen-Wei Xia; Li-Qing Xu; Wen-Wei Zhong; Jing-Jing Wei; Ning-Li Li; Jie Shao; Yun-Zhu Li; Shan-Chang Yu; Zi-Li Zhang
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

Review 6.  Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.

Authors:  Mari Kannagi
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 7.  Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Authors:  Yorifumi Satou; Masao Matsuoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

8.  Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.

Authors:  Elisabetta Capriotti; Eric C Vonderheid; Christopher J Thoburn; Mariusz A Wasik; David W Bahler; Allan D Hess
Journal:  Leuk Lymphoma       Date:  2008-06

9.  Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.

Authors:  Yoshihisa Yamano; Natsumi Araya; Tomoo Sato; Atae Utsunomiya; Kazuko Azakami; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Naoko Yagishita; Ryoji Fujii; Kusuki Nishioka; Steven Jacobson; Toshihiro Nakajima
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

10.  CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection.

Authors:  Coreen M Beaumier; Levelle D Harris; Simoy Goldstein; Nichole R Klatt; Sonya Whitted; John McGinty; Cristian Apetrei; Ivona Pandrea; Vanessa M Hirsch; Jason M Brenchley
Journal:  Nat Med       Date:  2009-06-14       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.